BURNING ROCK BIOTECH LTD-ADR (BNR) Stock Overview
USA - NASDAQ:BNR - US12233L2060 - ADR
BNR Key Statistics, Chart & Performance
The current stock price of BNR is 8.36 USD. In the past month the price increased by 0.72%. In the past year, price increased by 158.03%.
BNR Latest News, Press Relases and Analysis
BNR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.77 | 407.19B | ||
| AMGN | AMGEN INC | 13.3 | 156.19B | ||
| GILD | GILEAD SCIENCES INC | 15.14 | 145.40B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.07 | 104.55B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 60.36B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.37 | 59.85B | ||
| ARGX | ARGENX SE - ADR | 85.97 | 48.77B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.17 | 35.16B | ||
| INSM | INSMED INC | N/A | 34.31B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.54B | ||
| NTRA | NATERA INC | N/A | 23.23B | ||
| BIIB | BIOGEN INC | 9.15 | 21.49B |
Related stock screener links
About BNR
Company Profile
Burning Rock Biotech Ltd. engages in the investment of medical fields. The company is headquartered in Guangzhou, Guangdong and currently employs 674 full-time employees. The company went IPO on 2020-06-12. The firm operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Company Info
BURNING ROCK BIOTECH LTD-ADR
No. 5 Xingdao Ring Road North, International Bio Island
Guangzhou GUANGDONG 510005 CN
CEO: Yusheng Han
Employees: 786
Phone: 8618501641666
BURNING ROCK BIOTECH LTD-ADR / BNR FAQ
What is the stock price of BURNING ROCK BIOTECH LTD-ADR today?
The current stock price of BNR is 8.36 USD. The price decreased by -2.56% in the last trading session.
What is the ticker symbol for BURNING ROCK BIOTECH LTD-ADR stock?
The exchange symbol of BURNING ROCK BIOTECH LTD-ADR is BNR and it is listed on the Nasdaq exchange.
On which exchange is BNR stock listed?
BNR stock is listed on the Nasdaq exchange.
What is BURNING ROCK BIOTECH LTD-ADR worth?
BURNING ROCK BIOTECH LTD-ADR (BNR) has a market capitalization of 85.76M USD. This makes BNR a Micro Cap stock.
How many employees does BURNING ROCK BIOTECH LTD-ADR have?
BURNING ROCK BIOTECH LTD-ADR (BNR) currently has 786 employees.
What are the support and resistance levels for BURNING ROCK BIOTECH LTD-ADR (BNR) stock?
BURNING ROCK BIOTECH LTD-ADR (BNR) has a support level at 8.36 and a resistance level at 9.25. Check the full technical report for a detailed analysis of BNR support and resistance levels.
Is BURNING ROCK BIOTECH LTD-ADR (BNR) expected to grow?
The Revenue of BURNING ROCK BIOTECH LTD-ADR (BNR) is expected to grow by 48.35% in the next year. Check the estimates tab for more information on the BNR EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BURNING ROCK BIOTECH LTD-ADR (BNR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BNR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BNR, evaluating the profitability, health, valuation and growth aspects
- BURNING ROCK BIOTECH LTD-ADR (BNR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BURNING ROCK BIOTECH LTD-ADR (BNR) Sales and EPS estimates to see what analysts future expectations are.
- BURNING ROCK BIOTECH LTD-ADR (BNR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BURNING ROCK BIOTECH LTD-ADR (BNR) Insider and Institutional Ownership to learn about the owners and their transactions.
- BURNING ROCK BIOTECH LTD-ADR (BNR) Stock Chart to make your own analysis
- BURNING ROCK BIOTECH LTD-ADR (BNR) Latest news and press-releases to stay up to date.
Does BURNING ROCK BIOTECH LTD-ADR (BNR) stock pay dividends?
BNR does not pay a dividend.
When does BURNING ROCK BIOTECH LTD-ADR (BNR) report earnings?
BURNING ROCK BIOTECH LTD-ADR (BNR) will report earnings on 2025-12-02.
What is the Price/Earnings (PE) ratio of BURNING ROCK BIOTECH LTD-ADR (BNR)?
BURNING ROCK BIOTECH LTD-ADR (BNR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.99).
What is the Short Interest ratio of BURNING ROCK BIOTECH LTD-ADR (BNR) stock?
The outstanding short interest for BURNING ROCK BIOTECH LTD-ADR (BNR) is 0.61% of its float. Check the ownership tab for more information on the BNR short interest.
BNR Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to BNR. When comparing the yearly performance of all stocks, BNR is one of the better performing stocks in the market, outperforming 97.31% of all stocks.
BNR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BNR. BNR has a bad profitability rating. Also its financial health evaluation is rather negative.
BNR Financial Highlights
Over the last trailing twelve months BNR reported a non-GAAP Earnings per Share(EPS) of -1.99. The EPS increased by 96.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -17% | ||
| ROE | -24.86% | ||
| Debt/Equity | 0 |
BNR Forecast & Estimates
For the next year, analysts expect an EPS growth of -277.41% and a revenue growth 48.35% for BNR